MDA — Medapp SA Income Statement
0.000.00%
- PLN65.03m
- PLN69.53m
- PLN5.09m
Annual income statement for Medapp SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | PAS | PAS | PAS | PAS | PAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3.23 | 6.02 | 12.7 | 6.73 | 5.09 |
Cost of Revenue | |||||
Gross Profit | 2.61 | 5.47 | 10.9 | 5.23 | 3.88 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2.68 | 3.91 | 8.29 | 5.41 | 6.1 |
Operating Profit | 0.548 | 2.12 | 4.42 | 1.33 | -1.01 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.47 | 1.87 | 4.42 | 1.25 | -1.22 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.673 | 1.92 | 4.12 | 0.658 | -1.51 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.673 | 1.92 | 4.12 | 0.658 | -1.51 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.673 | 1.92 | 4.12 | 0.658 | -1.51 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.007 | 0.01 | 0.018 | 0.003 | -0.006 |
Dividends per Share |